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Effects of Chrysotile Co*exposure on BaP
Binding in Normal Human Fibroblasts
by Ming J. W. Chang,*t Narendra P. Singh*
and Ronald W. Hart*
The effects of chrysotile and benzo(a)pyrene (BaP) co-exposure on uptake, metabolism and BaP
binding to nucleic acids were investigated in normal human fibroblasts. A significant enhancement in
these parameters was found when co-exposure was carried out under serum-free conditions. In the
presence of serum, only a slight enhancement of BaP uptake was detected, while metabolism and
binding to nucleic acids were not affected over the 8-hr incubation period studied.
Introduction
In 1977, Saracci noted that asbestos and cigarette
smoking may act synergistically or even multiplica-
tively toproduce lung cancer (1). Results reported by
Hammond etal. (2) onrelative riskanalyses of a large
group of North American insulation workers sup-
ported the multiplicative model. Later, data col-
lected on chrysotile miners and millers from Quebec
and reported by McDonald etal.(3)supported a more
than additive but less than multiplicative synergistic
effectofasbestos and cigarette smoking.
Benzo(a)pyrene (BaP)is one ofseveral carcinogenic
components in cigarette smoke that have been impli-
cated in human respiratory neoplasms (4). The carci-
nogenic action of BaP in experimental animals has
been hypothesized to act through its ability to bind
to cellular DNA (5). On the other hand, the mecha-
nism by which asbestos exposure initiates pulmo-
nary tumors is unknown. It has been suggested that
asbestos may facilitate the phenotypic expression of
a transformed cell through the stimulation ofcellular
proliferation (6).
An enhanced uptake of BaP into biological sys-
tems in the presence of asbestos has recently been
reported by this and other laboratories (7- 9). This
study examined the effect of chrysotile co-exposure
on the uptake, metabolism and binding ofBaP in nor-
mal human fibroblast cell cultures in both the pres-
ence and absence of serum and concluded that in the
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presence of asbestos, a higher level of BaP is taken
up by the cell and is thus available for metabolic acti-
vation and subsequent macromolecular binding.
Materials and Methods
Cell Cultures
Normal human skin fibroblasts were cultivated as
described previously (6). Karyotype was checked and
shown to have a normal human chromosomal pat-
tern. Mycoplasm contamination was routinely
screened for by the Microbiology Services Division
of the National Center for Toxicological Research
and consistently found to be negative. At 24 hr fol-
lowing the seeding of 4.2 x 106 fibroblasts per 100
mm diameter Petri dish, or 24 hr after changing the
medium of a confluent fibroblast culture of the same
density, growth medium was removed and replaced
with one containing 3 ,ug/mL 3H-BaP (New England
Nuclear, Boston, MA, specific activity = 50 Ci/
mmole was diluted with Florisil purified nonradioac-
tive BaP to yield a specific activity of 211 mCi/
mmole) and 10 j*g/mL chrysotile (NIEHS, mean
width: 0.17j.m, mean length: 21 jim) with or without
10% fetal bovine serum (FBS, Gibco Laboratories,
Grand Island, NY) for 8 hr. Three plates per sample
group per experiment were used. A viable cell count
was performed on each sample by the trypan blue
exclusion method aspreviously reported(7).
Organic Solvent Extraction of Growth
Medium
The culture growth medium containing 3H-BaP
and its metabolites was collected after 8 hrofincuba-CHANG, SINGHAND HART
tion. An aliquot of medium of each sample was vigor-
ously mixed with an equal volume ofacetone in order
to denature any residual protein. Subsequently, an
equal volume of ethyl acetate was added to the ex-
traction mixture. The extraction was completed with
further vigorous mixing and by centrifugation of 3/4
of the full speed of an IEC table top centrifuge,
Model HN-S (approximately 2000 rpm). The organic
and aqueous phases were collected separately. The
radioactivity ofeach phase was determined by count-
ing an aliquot of it in the scintillant Aquassure (New
England Nuclear) with a Packard 3380 liquid scintil-
lation spectrometer.
Macromolecular Binding of 3H-BaP
Cell cultures at the end of the incubation period
were washed three times with phosphate-buffered
saline (PBS). Subsequently, cells were trypsinized
with 2 mL of 0.01% trypsin in 0.02% ethylenedi-
aminetetraacetic acid (EDTA, Fisher Scientific, Fair
Lawn, NJ) for 3-5 min (7). Trypsinization was termi-
nated by adding 3 mL of a growth medium contain-
ing 10% FBS. A well-dispersed 0.1 mL cell suspen-
sion per plate out of a total volume of 5 mL was used
for a viable cell count. The rest of the cells were col-
lected by low speed centrifugation (1000 g). The cell
pellet was washed once with SSC (0.15 M NaCl and
0.015Msodium citrate) at 40C and then resuspended
in 0.1 x SSC for 30 min to release the unbound 3H-
BaP before another low speed centrifugation. The
precipitate was then dissolved in 1% sodium dodecyl
sulfate (SDS, Sigma, St. Louis, MO) in SSC. Nucleic
acids (RNA and DNA) were extracted from the SDS-
dissolved solution by first making it 2 M in NaCl fol-
lowed by an extraction with an equal volume of
CHCl3:isoamyl alcohol (24:1) (10). The aqueous phase,
which contained nucleic acids, was collected after a
centrifugation at 2000 g for 12 min. RNA was hydro-
lyzed with 0.3NKOH at 370C for 18 hr. At the end of
the hydrolysis, the solution was acidified in an ice-
water bath with cold 50% perchloric acid (PCA, Mal-
linckrodt, St. Louis, MO) to a pH between 2 and 5(11).
The precipitate was further extracted for DNA with
a 5% PCA solution at 800C for 45 min. The nucleic
acids were quantitated by ultraviolet absorption at
260 nm. The radioactivities of the nucleic acids were
determined by liquid scintillation spectrometry as
described above.
Results and Discussion
Cotreatment with chrysotile (10 ,ug/mL) and BaP(3
,ug/mL) led to no observable cytotoxicity after 8 hr of
incubation in reseeded high density cell cultures but
did slightly induce cell killingin the confluent cell cul-
tures under serum-free conditions (Table 1). The cell
densities in these two cultures were approximately
equal at the beginning of the experiment (50,000
cells/cm2 dish), but the percent of mitotic figures was
less under continuous confluent culture conditions.
By analyzing the total radioactivity left in the me-
dium at the end of 8 hr of incubation, we found that
in the presence of 10% FBS, the uptake of 3H-BaP
was essentially the same in control and chrysotile-
treated reseeded cultures. An enhanced uptake ofla-
beled BaP in the continuous confluent chrysotile-
treated cultures was also observed(Table 1,p <0.02).
Approximately twice as much of the 3H-BaP was
taken up by the control cultures in the absence of
serum. However, the presence of10,g/mL chrysotile
further enhanced uptake by approximately 35-40%
over control levels. A similar observation was re-
ported earlier (7), when a lower cell density (0.1 x
106/dish) and a longer incubation time (24 hr) were
used. As would be expected due to the low capacity
of normal human skin fibroblasts to metabolize BaP
(12), when an aliquot ofthe collected growth medium
was extracted with organic solvents, the major part
of the radioactivity measured in the organic phase
was due to the nonmetabolized 3H-BaP. Indeed, as
shown in Table 2, 70-80% of the radioactivity from
the serum-free medium was extracted into the or-
ganic phase. While the recovery of radioactivity in
the serum-containing medium was incomplete, only
7-8% of the total applied radioactivity was con-
verted to water soluble-metabolites including sulfate
esters, glucuronides and glutathione conjugates (13)
and the other organic solvent-extractable metabo-
lites, including minute quantities of diols, quinones
and phenols (13). The less than 100°h recovery of ra-
dioactivity in the organic and aqueous phases of the
Table 1. Effects ofchrysotile cotreatment on 3H-BaP uptake by and viability ofnormal human fibroblasts.a
Radioactivity left in medium, % Viable cells x 10-I
Culture Serum Control Chrysotile Control Chrysotile
Reseeded + 76.3 ± 1.4 76.3 ± 1.6 30.6 ± 2.0 31.7 ± 2.1
Reseeded - 51.3 ± 1.1 31.7 ± 1.6 32.2 ± 0.3 32.5 ±0.8
Confluent + 76.2 ± 1.7 71.3 ± 0.9 45.9 ± 0.2 44.7 ± 0.4
Confluent - 50.0 + 2.6 32.4 ± 1.3 39.6 ± 0.2 36.3 ± 0.2
a Cultures in 100 mm Petri dishes were treated with 10 mL each of 10 Mg/mL asbestos and 3pg/mL3H-BaP for 8 hr. Each experi-
ment was done in triplicate and expressed as value ± SD.
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Table 2. Recovery of organic and water-soluble 3H-BaP metabolites from culture medium of human fibroblasts.a
Radioactivity in organic phase, % Radioactivity in aqueous phase, %
Culture Serum Control Chrysotile Control Chrysotile
Reseeded + 69.7 ± 0.8 64.6 ± 0.8 9.5 ± 0.2 9.0 + 0.5
Reseeded - 82.2 ± 0.7 78.1 ± 4.3 14.8 ± 1.0 20.9 + 1.6
Confluent + 44.9 ± 0.6 47.9 ± 2.6 11.4 + 0.6 11.8 + 0.7
Confluent - 69.9 ± 1.9 70.1 ± 5.5 27.4 ± 1.5 33.7 ± 1.0
a Extraction was done with equal volumes ofacetone to denature the proteins and then further extracted with additional equal vol-
umes ofethyl acetate (1:1:1); in (value ± SD).
serum plus medium may be due to an association,
either covalently or noncovalently, of the BaP or its
metabolites withdenatured proteins which settled at
the interphase. In the presence of serum, there was
no observable difference in the amount ofwater-solu-
ble metabolites recovered between the control and
the asbestos-treated cultures. When serum was with-
held from the growth medium, a significantly higher
percentage of radioactivity was recovered in the
aqueous phase of the asbestos-treated medium, indi-
cating that more BaP was metabolized in the treated
culture than the control. The initial metabolic activa-
tion of BaP is carried out by the cytochrome P450
enzyme system (14). A minute portion of the metabo-
lites is eventually transformed to electrophiles which
covalently bind to any available nucleophilic centers
on cellular macromolecules, thereby forming ad-
ducts. Since cellular proteins and RNAs are con-
stantly turned over, only DNA modifications (e.g.,
DNA adducts) are assumed to be involved in the
manifestation of the long term effects of such dam-
age. Those DNA adducts not removed prior to DNA
replication are believed to lead to an infidelity of
DNA replication which is subsequently passed on in
the genetic material to the daughter cell (11, 15).
The BaP-RNA and the BaP-DNA binding of nor-
mal human skin fibroblasts in the presence or ab-
sence of chrysotile treatment are summarized in
Table 3. In the presence of serum, the BaP-nucleic
acid binding is not modified by asbestos treatment,
while under serum-free cultures, there is a signifi-
cant enhancement ofBaP-nucleic acid binding in the
presence ofchrysotile for both the reseeded and con-
fluent cultures. The observed enhancement in bind-
ing is interpreted to mean simply that more BaP is
available intracellularly as a substrate for the cyto-
chrome P450 enzymes. The binding data substanti-
ate the observation that under serum-free conditions
there is an increased uptake of BaP in the presence
of chrysotile. Previously, it was demonstrated that
chrysotile can adsorb BaP easily in the absence of
serum and the adsorbed BaP was rapidly eluted
upon the addition of serum suggesting that under
serum-free conditions, chrysotile acts as a vehicle for
bringing BaP into cells (7). This does not, however,
Table 3. Chrysotile effects on 3H-BaP-nucleic acid binding
in normal human fibroblasts.a
CPM260 treated / CPM/OD26O control
Culture Serum RNA DNA
Reseeded + 1.03 ±0.16 1.15 ±0.10
Reseeded - 1.29 ± 0.39 2.76 ± 0.33
Confluent + 0.99 ± 0.03 1.00 ± 0.17
Confluent - 1.72 ± 0.41 2.21 ± 0.48
a RNA was hydrolyzed with 0.3 N KOH at 37°C for 18 hr be-
fore DNA was extracted with 5% PCA at 800C for 45 min; in
value ± SD.
appear to be the case under serum-added conditions,
which are more representative ofin vivo conditions.
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